查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589604

藥品安全市場：按功能、交付模式和最終用戶分類 - 2025-2030 年全球預測

Drug Safety Market by Functionality (ADR Reporting, Drug Safety Audits, Fully Integrated Software), Delivery Mode (On-Demand, On-Premise), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥品安全市場價值為115.6億美元，預計到2024年將達到140.6億美元，複合年成長率為21.70%，到2030年將達到457.4億美元。

藥品安全市場在製藥業中發揮著至關重要的作用，其重點是透過識別、評估和減輕與藥品使用相關的風險來確保藥品的安全性、有效性和品質。藥物安全考慮到嚴格的全球藥物指南，對於防止副作用和確保監管合規性是必要的。應用範圍從臨床前測試到上市後監測，最終用戶包括製藥公司、監管機構、醫療保健提供者和患者。影響成長的關鍵因素包括慢性病盛行率上升、藥物開發活動活性化、監管要求收緊以及在藥物安全檢測過程中採用人工智慧和巨量資料分析等先進技術。然而，市場面臨安全測試和合規相關高成本、監管環境複雜以及核准流程冗長等限制。目前的商機在於個人化醫療的擴展，這需要更個人化的藥物安全評估，以及更加重視以患者為中心的方法，從而推動對即時安全監測解決方案的需求。公司可以透過投資創新的安全管理解決方案和夥伴關係關係來抓住這些機會，以利用技術進步。此外，向醫療保健基礎設施快速發展的新興市場擴張也提供了良好的前景。創新和研究可以集中在整合機器學習和人工智慧，以簡化安全流程，更有效地預測不利事件，並改善整體藥物開發時間表。儘管存在資料隱私問題和國際監管差異等挑戰，但增強安全通訊協定的顛覆性創新的市場已經成熟。隨著越來越多的審查和對透明度的要求繼續塑造這個充滿活力的行業，保持領先地位需要利用技術整合和策略聯盟來推動市場領導地位和永續成長。

主要市場統計
基準年[2023] 115.6億美元
預測年份 [2024] 140.6億美元
預測年份 [2030] 457.4億美元
複合年成長率（%） 21.70%

市場動態：揭示快速發展的藥品安全市場的關鍵市場洞察

供需的動態交互作用正在改變藥品安全市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 吸煙人口增加
    • 增加病人安全問題
    • 企業對外包服務的需求增加
  • 市場限制因素
    • 臨床試驗問題
  • 市場機會
    • 活性化研發活動
    • 更多採用藥物安全性來推動新藥上市
  • 市場挑戰
    • 藥物的副作用

波特五力：駕馭藥品安全市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥品安全市場的外部影響

外部宏觀環境因素對藥品安全市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解藥品安全市場的競爭格局

對藥品安全市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣藥物安全市場供應商的績效評估

FPNV定位矩陣是評估藥品安全市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

戰略分析和建議繪製藥品安全市場的成功之路

藥品安全市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 吸煙成癮的人口增加
      • 增加病人安全問題
      • 玩家對外包服務的需求增加
    • 抑制因素
      • 臨床試驗問題
    • 機會
      • 增加研發活動
      • 擴大藥物安全的採用以加速新藥上市
    • 任務
      • 藥物副作用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 藥品安全市場的功能

  • ADR報告
  • 藥品安全審核
  • 完全整合的軟體
  • 問題追蹤

第7章 依交付方式分類的藥品安全市場

  • 一經請求
  • 本地

第8章 藥品安全市場：依最終使用者分類

  • 業務流程外包
  • 合約調查機構
  • 製藥和生物技術公司

第9章美洲藥品安全市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太藥品安全市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲藥品安全市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AB CUBE SAS
  • Accenture, plc
  • ArisGlobal LLC
  • Cinven
  • Cognizant Technology Solutions Corp
  • Ergomed PLC
  • EXTEDO GmbH
  • Genpact
  • HCL Technologies Limited
  • Indigene Pharmaceuticals, Inc.
  • IQVIA Inc.
  • Medco Health Solutions, Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • PPD Inc
  • Sarjen Systems Pvt. Ltd
  • Sparta Systems Inc.
  • Syneos Health
  • Worldwide Clinical Trials
Product Code: MRR-030EE48515FE

The Drug Safety Market was valued at USD 11.56 billion in 2023, expected to reach USD 14.06 billion in 2024, and is projected to grow at a CAGR of 21.70%, to USD 45.74 billion by 2030.

The drug safety market plays a critical role in the pharmaceutical industry, focused on ensuring the safety, efficacy, and quality of drugs by identifying, evaluating, and mitigating risks associated with their use. Drug safety is necessary to prevent adverse effects and ensure regulatory compliance, given the stringent guidelines worldwide for pharmaceuticals. The application scope ranges from pre-clinical trials to post-marketing surveillance, with end-users including pharmaceutical companies, regulatory authorities, healthcare providers, and patients. Key influencing growth factors include the rising prevalence of chronic diseases, increasing drug development activities, heightened regulatory requirements, and the adoption of advanced technologies such as AI and big data analytics in pharmacovigilance processes. However, the market faces limitations, including high costs associated with safety testing and compliance, complex regulatory landscapes, and time-consuming approval processes. Current opportunities lie in the expansion of personalized medicine, which requires more tailored drug safety evaluations, and the growing emphasis on patient-centric approaches that drive demand for real-time safety monitoring solutions. Companies can seize these opportunities by investing in innovative safety management solutions and partnerships to leverage technological advancements. Additionally, expanding into emerging markets, where healthcare infrastructure is rapidly developing, presents lucrative prospects. Innovation and research can focus on integrating machine learning and AI to streamline safety processes, predicting adverse outcomes more efficiently, and improving overall drug development timelines. Despite challenges, such as data privacy concerns and varying international regulations, the market is ripe for disruptive innovations that enhance safety protocols. As heightened scrutiny and transparency demands continue to shape this dynamic sector, staying ahead requires a keen focus on technological integration and strategic collaborations to drive market leadership and sustainable growth.

KEY MARKET STATISTICS
Base Year [2023] USD 11.56 billion
Estimated Year [2024] USD 14.06 billion
Forecast Year [2030] USD 45.74 billion
CAGR (%) 21.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Safety Market

The Drug Safety Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing population addicted to smoking
    • Escalating patient safety issues
    • Rise in demand for outsourcing services by players
  • Market Restraints
    • Issues related to clinical trials
  • Market Opportunities
    • Rising R&D activities
    • Increasing adoption of drug safety facilitating the launch of new drugs
  • Market Challenges
    • Adverse effects of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Drug Safety Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Safety Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Safety Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Safety Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Safety Market

A detailed market share analysis in the Drug Safety Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Safety Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Safety Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Safety Market

A strategic analysis of the Drug Safety Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Safety Market, highlighting leading vendors and their innovative profiles. These include AB CUBE S.A.S, Accenture, plc, ArisGlobal LLC, Cinven, Cognizant Technology Solutions Corp, Ergomed PLC, EXTEDO GmbH, Genpact, HCL Technologies Limited, Indigene Pharmaceuticals, Inc., IQVIA Inc., Medco Health Solutions, Inc., Oracle Corporation, Parexel International Corporation, PPD Inc, Sarjen Systems Pvt. Ltd, Sparta Systems Inc., Syneos Health, and Worldwide Clinical Trials.

Market Segmentation & Coverage

This research report categorizes the Drug Safety Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Functionality, market is studied across ADR Reporting, Drug Safety Audits, Fully Integrated Software, and Issue Tracking.
  • Based on Delivery Mode, market is studied across On-Demand and On-Premise.
  • Based on End User, market is studied across Business Process Outsourcing, Contract Research Organizations, and Pharma & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing population addicted to smoking
      • 5.1.1.2. Escalating patient safety issues
      • 5.1.1.3. Rise in demand for outsourcing services by players
    • 5.1.2. Restraints
      • 5.1.2.1. Issues related to clinical trials
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising R&D activities
      • 5.1.3.2. Increasing adoption of drug safety facilitating the launch of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Safety Market, by Functionality

  • 6.1. Introduction
  • 6.2. ADR Reporting
  • 6.3. Drug Safety Audits
  • 6.4. Fully Integrated Software
  • 6.5. Issue Tracking

7. Drug Safety Market, by Delivery Mode

  • 7.1. Introduction
  • 7.2. On-Demand
  • 7.3. On-Premise

8. Drug Safety Market, by End User

  • 8.1. Introduction
  • 8.2. Business Process Outsourcing
  • 8.3. Contract Research Organizations
  • 8.4. Pharma & Biotech Companies

9. Americas Drug Safety Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug Safety Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug Safety Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AB CUBE S.A.S
  • 2. Accenture, plc
  • 3. ArisGlobal LLC
  • 4. Cinven
  • 5. Cognizant Technology Solutions Corp
  • 6. Ergomed PLC
  • 7. EXTEDO GmbH
  • 8. Genpact
  • 9. HCL Technologies Limited
  • 10. Indigene Pharmaceuticals, Inc.
  • 11. IQVIA Inc.
  • 12. Medco Health Solutions, Inc.
  • 13. Oracle Corporation
  • 14. Parexel International Corporation
  • 15. PPD Inc
  • 16. Sarjen Systems Pvt. Ltd
  • 17. Sparta Systems Inc.
  • 18. Syneos Health
  • 19. Worldwide Clinical Trials

LIST OF FIGURES

  • FIGURE 1. DRUG SAFETY MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG SAFETY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG SAFETY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG SAFETY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG SAFETY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG SAFETY MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG SAFETY MARKET SIZE, BY ADR REPORTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG SAFETY MARKET SIZE, BY DRUG SAFETY AUDITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG SAFETY MARKET SIZE, BY FULLY INTEGRATED SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG SAFETY MARKET SIZE, BY ISSUE TRACKING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-DEMAND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG SAFETY MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG SAFETY MARKET SIZE, BY BUSINESS PROCESS OUTSOURCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG SAFETY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG SAFETY MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG SAFETY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG SAFETY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG SAFETY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. DRUG SAFETY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. DRUG SAFETY MARKET, FPNV POSITIONING MATRIX, 2023